This site is fully related to medical laboratory information for public and health care professionals.
Introduction The core difference between these forms of drug-resistant tuberculosis (DR-TB) lies in which specific medications the Mycobacterium tuberculosis bacteria can survive. As resistance progresses from MDR-TB to Pre-XDR-TB and finally XDR-TB, treatment becomes longer, more complex, and relies on scarcer second-line drugs. Differences Comparison …
Introduction Second-line drug susceptibility testing (SL-DST) for tuberculosis is a crucial laboratory procedure designed to detect resistance to anti-TB drugs used when first-line treatment fails (i.e., multidrug-resistant TB – MDR-TB). Principle SL-DST measures the susceptibility of Mycobacterium tuberculosis to specific agents by determining the Critical …
Introduction The Line Probe Assay (LPA) is a rapid molecular diagnostic test used to detect Mycobacterium tuberculosis complex (MTBC) and its resistance to anti-tuberculosis drugs. It identifies specific mutations in the genes associated with drug resistance by hybridizing amplified DNA onto membrane strips. The LPA is a …